Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-06-09

Clinical Trial Update: Drug Therapy Induced Weight Loss to Improve Blood Vessel Function in Subjects With Obesity [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating a drug therapy for weight loss to improve vascular function in individuals with obesity was terminated; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Iowa | Conditions: Obesity, Metabolic Syndrome X | Phase 2 | Status: TERMINATED | Results posted: 2021-06-09